Join to View Full Profile
2441 West State Road 426Suite 2011Oviedo, FL 32765
Phone+1 407-678-6888
Fax+1 407-359-5454
Dr. Block is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Bradley Block is a Family Medicine specialist based in Oviedo, FL. He completed his residency in Family Medicine at Geisinger Health System in 1992, following his graduation from Lewis Katz School of Medicine at Temple University in 1989. His professional interests include wellness, and he has contributed to numerous publications in reputable medical journals such as The New England Journal of Medicine and Lancet, focusing primarily on diabetes, cardiovascular safety, and hypertension. Dr. Block has also been involved in several clinical trials, including studies on atrial fibrillation, triglyceride management, and diabetes treatment. He was recognized as a Fellow by the American Academy of Family Physicians in 2011 and has received CMS Meaningful Use Stage 1 Certification.
Education & Training
Geisinger Health System (Wilkes-Barre)Residency, Family Medicine, 1989 - 1992
Lewis Katz School of Medicine at Temple UniversityClass of 1989
Certifications & Licensure
FL State Medical License 1992 - 2027
PA State Medical License 1991 - 1998
American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2011, 2013-2017
- CMS Meaningful Use Stage 2 Certification eClinicalWorks, eClinicalWorks, LLC, 2011, 2013-2017
- Fellow (FAAFP) American Academy of Family Physicians, 2011
Clinical Trials
- Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism Start of enrollment: 2011 Sep 01
- A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes Start of enrollment: 2014 Apr 01
- Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL Start of enrollment: 2017 Apr 06
Publications & Presentations
PubMed
- 12 citationsA novel non-PPARgamma insulin sensitizer: MLR-1023 clinicalproof-of-concept in type 2 diabetes mellitusMoon Kyu Lee, Sin Gon Kim, Elaine Watkins, Min Kyong Moon, Sang Youl Rhee
Journal of Diabetes and Its Complications. 2020-05-01 - 60 citationsSolriamfetol for the Treatment of Excessive Sleepiness in OSA: A Placebo-Controlled Randomized Withdrawal StudyPatrick J. Strollo, Jan Hedner, Nancy A. Collop, Daniel G. Lorch, Dan Chen
Chest. 2019-02-01 - 56 citationsEffect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trialErin A. Bohula, Benjamin M. Scirica, Silvio E Inzucchi, Darren K. McGuire, Anthony C Keech
Lancet. 2018-11-24
Authored Content
- How We Improved Our Practice and Our Bottom Line With a New EMR SystemJune 2008
Professional Memberships
- Fellow
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
